ドルテグラビル
hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO
↑ "WHO recommends dolutegravir as preferred HIV treatment option in all populations". World Health Organization (Press release). 2019年7月22日閲覧。
1 2 3 “テビケイ錠50mg 添付文書”. www.pmda.go.jp. PMDA. 2021年5月31日閲覧。
↑ FDA approves new drug to treat HIV infection https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm364744.htm August 12, 2013
1 2 3 "FDA Approves Drug to Treat Infants and Children with HIV". U.S. Food and Drug Administration (FDA) (Press release). 12 June 2020. 2020年6月12日閲覧。
↑ “U.S.